1.775
price down icon3.53%   -0.065
 
loading

Gain Therapeutics Inc Aktie (GANX) Neueste Nachrichten

pulisher
03:57 AM

Why Gain Therapeutics Inc. stock remains on buy listsPortfolio Growth Summary & Smart Money Movement Tracker - newser.com

03:57 AM
pulisher
03:48 AM

Gain Therapeutics Inc. stock outlook for YEARWeekly Gains Report & Verified Momentum Stock Alerts - newser.com

03:48 AM
pulisher
01:37 AM

Building trade automation scripts for Gain Therapeutics Inc.Weekly Stock Report & Safe Swing Trade Setups - newser.com

01:37 AM
pulisher
01:29 AM

Sentiment analysis tools applied to Gain Therapeutics Inc.Trend Reversal & Fast Exit/Entry Strategy Plans - newser.com

01:29 AM
pulisher
Nov 03, 2025

Is Gain Therapeutics Inc. stock ready for a breakoutSell Signal & AI Enhanced Trade Execution Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Gain Therapeutics Inc. stock go up soonQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Advanced analytics toolkit walkthrough for Gain Therapeutics Inc.2025 Pullback Review & Daily Stock Trend Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Using R and stats models for Gain Therapeutics Inc. forecastingTrade Entry Report & Weekly Stock Breakout Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Gain Therapeutics Inc. stock trend outlook and recovery pathPortfolio Gains Summary & Daily Price Action Insights - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Gain Therapeutics Inc. stock undervalued vs historical averages2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Gain Therapeutics Inc. stock entering bullish territoryTrade Volume Summary & Consistent Profit Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Gain Therapeutics Inc. stock a dividend growth opportunity2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Gain Therapeutics Inc. stock a buy before product launchesQuarterly Portfolio Review & AI Driven Price Predictions - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Using Python tools to backtest Gain Therapeutics Inc. strategies2025 Sector Review & Low Risk High Win Rate Picks - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

How risky is Gain Therapeutics Inc. stock now2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can machine learning forecast Gain Therapeutics Inc. recoveryTrade Ideas & Long Hold Capital Preservation Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Can Gain Therapeutics Inc. stock deliver sustainable ROETrade Volume Report & Weekly Setup with ROI Potential - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Will Gain Therapeutics Inc. stock deliver strong dividend growthJuly 2025 Levels & Smart Allocation Stock Tips - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Gain Therapeutics Advances Parkinson’s Treatment with GT-02287 Study - MSN

Oct 31, 2025
pulisher
Oct 30, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Short Interest Up 200.7% in October - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Gain Therapeutics, Inc. (GANX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Gain Therapeutics to Present at Neuroscience 2025 - The Manila Times

Oct 30, 2025
pulisher
Oct 30, 2025

Gain Therapeutics (NASDAQ: GANX) to present GT-02287 poster at Society for Neuroscience - Stock Titan

Oct 30, 2025
pulisher
Oct 30, 2025

What technical charts say about Gain Therapeutics Inc. stock2025 Historical Comparison & Fast Gain Stock Trading Tips - newser.com

Oct 30, 2025
pulisher
Oct 29, 2025

What drives Gain Therapeutics Inc stock priceTechnical Breakout Signals & Free Real-Time Stock Market Data - earlytimes.in

Oct 29, 2025
$37.95
price up icon 1.71%
$29.15
price up icon 1.67%
$102.21
price up icon 0.62%
$103.58
price down icon 0.18%
biotechnology ONC
$315.16
price up icon 1.13%
$185.89
price down icon 0.42%
Kapitalisierung:     |  Volumen (24h):